SCHEMBL7683538

SCHEMBL7683538

Cc1ccc(Cl)cc1C1CC(=O)c2c(C)ccnc2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7685259 0.91 MAP1LC3B (0.43)
SCHEMBL7687648 0.89
Hydrochloric Acid SCHEMBL7687669 0.89
SCHEMBL7685366 0.87 LMNA (0.41)
SCHEMBL7690415 0.87 GRM7 (0.39)
SCHEMBL6804541 0.85 ALPL (0.41)
SCHEMBL7683162 0.81 HSP90AA1 (0.42)
SCHEMBL7687703 0.81
SCHEMBL6797519 0.81 TP53 (0.47)
SCHEMBL7678938 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6350749-B1 SODIUM CHANNEL MODULATORS, ANTIARRHYTHMIA AND HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS, ANGINA PECTORIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-02-26 US disclosed
EP-1057812-A1 AMINOGUANIDINE HYDRAZONE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND DRUGS THEREOF Takeda Chemical Industries, Ltd. (JP) 2000-12-06 EP disclosed
EP-0950418-A2 Composition for preventing or treating ischemic disease Takeda Chemical Industries, Ltd. (JP) 1999-10-20 EP disclosed